Literature DB >> 2013897

Modern treatment strategies for patients with epilepsy: a review.

J S Duncan1.   

Abstract

Of patients who develop epilepsy 70-80% will become seizure free, the remaining 20% are the most difficult to treat satisfactorily. Eighty per cent of patients are best treated with a single drug. Stepwise treatment plans for the treatment of newly diagnosed patients and for the evaluation of patients with chronic epilepsy are suggested. There is a lack of consensus regarding the rate at which to taper antiepileptic drugs being discontinued in patients with active epilepsy. There are arguments for making drug changes rapidly; these arguments and strategies for managing the withdrawal of individual drugs are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013897      PMCID: PMC1293137          DOI: 10.1177/014107689108400315

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  27 in total

1.  Magnetic resonance imaging (1.5 tesla) in patients with intractable focal seizures.

Authors:  R P Lesser; M T Modic; M A Weinstein; P M Duchesneau; H Lüders; D S Dinner; H H Morris; M Estes; S M Chou; J F Hahn
Journal:  Arch Neurol       Date:  1986-04

2.  Seizure management with minimal medications in institutionalized mentally retarded epileptics. A prospective study. First report after 4 1/2 years of follow up.

Authors:  N Alvarez; J Hazlett
Journal:  Clin Electroencephalogr       Date:  1983-07

3.  Unnecessary polypharmacy in patients with frequent seizures.

Authors:  N Callaghan; R O'Dwyer; J Keating
Journal:  Acta Neurol Scand       Date:  1984-01       Impact factor: 3.209

4.  Rationalisation of therapy in severe epilepsy.

Authors:  E J Roman; N Buchanan; J B Lambert; N Barrah
Journal:  Aust N Z J Med       Date:  1983-12

5.  Alternative single anticonvulsant drug therapy for refractory epilepsy.

Authors:  D Schmidt; K Richter
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

6.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

Authors:  R H Mattson; J A Cramer; J F Collins; D B Smith; A V Delgado-Escueta; T R Browne; P D Williamson; D M Treiman; J O McNamara; C B McCutchen
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

7.  When do epileptic patients need treatment? Starting and stopping medication.

Authors:  D Chadwick; E H Reynolds
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

8.  Reduction of polypharmacy for epilepsy in an institution for the retarded.

Authors:  H S Bennett; T Dunlop; P Ziring
Journal:  Dev Med Child Neurol       Date:  1983-12       Impact factor: 5.449

9.  Reduction of polypharmacy in epileptic patients.

Authors:  P Albright; J Bruni
Journal:  Arch Neurol       Date:  1985-08

10.  Reduction of two-drug therapy in intractable epilepsy.

Authors:  D Schmidt
Journal:  Epilepsia       Date:  1983-06       Impact factor: 5.864

View more
  3 in total

1.  The economic effects of introducing vigabatrin, a new antiepileptic medication.

Authors:  D Reinharz; W Kennedy; A P Contandriopoulos; G Tessier; F Champagne
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

2.  Epilepsy and quality of life research.

Authors:  G Scambler
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 18.000

3.  Managing patient adherence and quality of life in epilepsy.

Authors:  Joanne Eatock; Gus A Baker
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.